M. Skov
{"title":"抗ige (Omalizumab)治疗囊性纤维化患者ABPA:类固醇治疗的替代方案?","authors":"M. Skov","doi":"10.23937/2572-3308.1510039","DOIUrl":null,"url":null,"abstract":"Citation: Skov M (2019) Anti-IgE (Omalizumab) in the Management of ABPA among Cystic Fibrosis Patients: An Alternative to Steroid Treatment?. Int J Aller Medications 5:039. doi.org/10.23937/25723308.1510039 Accepted: May 23, 2019: Published: May 25, 2019 Copyright: © 2019 Skov M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-IgE (Omalizumab) in the Management of ABPA among Cystic Fibrosis Patients: An Alternative to Steroid Treatment?\",\"authors\":\"M. Skov\",\"doi\":\"10.23937/2572-3308.1510039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Citation: Skov M (2019) Anti-IgE (Omalizumab) in the Management of ABPA among Cystic Fibrosis Patients: An Alternative to Steroid Treatment?. Int J Aller Medications 5:039. doi.org/10.23937/25723308.1510039 Accepted: May 23, 2019: Published: May 25, 2019 Copyright: © 2019 Skov M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications\",\"PeriodicalId\":138186,\"journal\":{\"name\":\"International Journal of Allergy Medications\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Allergy Medications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2572-3308.1510039\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Allergy Medications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2572-3308.1510039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Anti-IgE (Omalizumab) in the Management of ABPA among Cystic Fibrosis Patients: An Alternative to Steroid Treatment?
Citation: Skov M (2019) Anti-IgE (Omalizumab) in the Management of ABPA among Cystic Fibrosis Patients: An Alternative to Steroid Treatment?. Int J Aller Medications 5:039. doi.org/10.23937/25723308.1510039 Accepted: May 23, 2019: Published: May 25, 2019 Copyright: © 2019 Skov M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
